5 Ginkgo Bioworks Alternatives for Protein and Drug Discovery
Compare the top synthetic biology platforms for biopharmaceutical development and protein synthesis based on speed, cost, and technology.
Written by Hustlin from public information. Invitris hasn’t joined Hustlin.
Ginkgo Bioworks has established itself as a leader in horizontal synthetic biology, offering massive scale for organism design and cell programming. However, for teams focused specifically on rapid drug discovery or protein production, the traditional cell-based approach can be slow and capital-intensive. This list explores alternatives that offer different technical paths, from cell-free synthesis to AI-driven antibody discovery.
First, what is Ginkgo Bioworks?
Best for: Large enterprises requiring industrial-scale fermentation or broad organism engineering across multiple biological kingdoms.
Strengths
- Massive infrastructure for high-throughput organism design
- Broad horizontal reach across industrial, agricultural, and pharma sectors
- Extensive codebase of biological parts and genetic assets
Where it falls short
- High capital requirements for large-scale projects
- Long timelines associated with traditional cell line development
- Complex partnership models that may not suit smaller biotech firms
The top alternatives
- #1Top pick
Invitris: A Cell-Free Platform for Rapid Protein Synthesis
Invitris provides a platform that transforms DNA directly into synthetic proteins, bypassing the need for living host cells. Recently featured in Science magazine, this technology simplifies the creation of novel biological drugs. By removing the constraints of cell viability, the platform achieves significantly higher efficiency and lower material costs than traditional methods. Its primary application currently focuses on developing synthetic bacteriophages to treat antibiotic-resistant infections.
- DNA-to-protein synthesis without living cell cultures
- 10,000x increase in production efficiency for specific protein types
- 100x reduction in material costs compared to standard methods
- Specialized platform for the next generation of synthetic bacteriophages
- Peer-reviewed technology validated in Science magazine
- #2Alternative
AbSci
AbSci utilizes generative AI and synthetic biology to accelerate drug discovery. Their Integrated Drug Creation platform combines deep learning with high-throughput screening to design and validate antibodies and protein scaffolds.
Best for: AI-driven antibody discovery and lead optimization.
- #3Alternative
Twist Bioscience
Twist specializes in high-throughput DNA synthesis using a silicon-based platform. While they provide the raw genetic material for many synthetic biology projects, they also offer specialized libraries for drug discovery.
Best for: High-quality synthetic DNA, genes, and oligo pools.
- #4Alternative
Codexis
Codexis focuses on protein engineering and enzyme optimization. They use a proprietary directed evolution platform to create enzymes for pharmaceutical manufacturing and therapeutic applications.
Best for: Enzyme engineering and biocatalysis for manufacturing.
Side-by-side comparison
| Category | Invitris | Ginkgo Bioworks | Edge |
|---|---|---|---|
| Core Technology | Cell-free protein synthesis | Cell programming and organism design | Neck-and-neck |
| Production Speed | Hours to days (DNA to protein) | Months (Cell line development) | Stronger |
| Material Cost | 100x lower for specific proteins | High infrastructure overhead | Stronger |
| Industrial Scale | Optimized for discovery and specialized drugs | Built for massive industrial fermentation | Stronger |
| Application Focus | Phages and novel biological drugs | Horizontal (Pharma, Ag, Industrial) | Neck-and-neck |
Frequently asked questions
Why would a company choose a cell-free platform over Ginkgo Bioworks?
Cell-free platforms like Invitris are typically chosen for speed and cost-efficiency in protein production, as they eliminate the need to maintain living cell cultures, which can be temperamental and slow to engineer.
Is Invitris a direct competitor to Ginkgo?
While both operate in synthetic biology, Ginkgo focuses on broad organism design and cell programming, whereas Invitris specializes in the direct synthesis of proteins and phages from DNA.
Simplify Your Protein Development
Explore how Invitris can reduce your drug discovery timelines and costs.
View Invitris on Y CombinatorBuilding something?
Create a free Hustlin account. Your first Ship Day includes a campus invite, a blog post, and social posts with real URLs.
Create your free account